Compugen (CGEN) Short-term Investments (2009 - 2026)
Compugen's (CGEN) quarterly Short-term Investments came in at $79.3 million in Q1 2026, up 40.43% year-on-year from $56.5 million in Q1 2025, and up 73.33% quarter-over-quarter from $45.8 million in Q4 2025.
Compugen (CGEN) Short-term Investments (2009 - 2026) Analysis & Trends
Compugen has disclosed Short-term Investments across 18 years of filings, most recently posting $79.3 million for Q1 2026.
- Short-term Investments for Q1 2026 came in at $79.3 million, up 40.43% year-over-year; the trailing twelve-month figure through Mar 2026 was $79.3 million (up 40.43% YoY), and the FY2025 annual result was $45.8 million, down 25.47% from the prior year.
- Short-term Investments came in at $79.3 million for Q1 2026 at Compugen, up from $45.8 million in the prior quarter.
- In the past five years, Short-term Investments ranged from a high of $88.9 million in Q2 2022 to a low of $25.1 million in Q4 2023.
- The 5-year median for Short-term Investments is $56.5 million (2025), against an average of $57.4 million.
- Across the five-year window, Short-term Investments sank 50.18% in 2023 and soared 145.07% in 2024, its largest moves.
- Compugen's Short-term Investments stood at $88.9 million in 2022, then tumbled by 71.82% to $25.1 million in 2023, then jumped by 145.07% to $61.4 million in 2024, then slipped by 25.47% to $45.8 million in 2025, then jumped by 73.33% to $79.3 million in 2026.
- The last three Short-term Investments figures came in at $79.3 million (Q1 2026), $45.8 million (Q4 2025), and $51.9 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - |
| 10 | Compugen | 189.59 Mn | 97.83 Mn | 352,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 79.32 Mn |
| Dec 31, 2025 | 45.76 Mn |
| Sep 30, 2025 | 51.91 Mn |
| Jun 30, 2025 | 58.54 Mn |
| Mar 31, 2025 | 56.48 Mn |
| Dec 31, 2024 | 61.40 Mn |
| Sep 30, 2024 | 72.35 Mn |
| Jun 30, 2024 | 47.44 Mn |
| Dec 31, 2023 | 25.05 Mn |
| Jun 30, 2023 | 44.30 Mn |
| Jun 30, 2022 | 88.92 Mn |
| Dec 31, 2021 | 109.25 Mn |
| Jun 30, 2021 | 102.56 Mn |
| Dec 31, 2020 | 116.62 Mn |
| Jun 30, 2020 | 122.96 Mn |
| Dec 31, 2019 | 34.04 Mn |
| Jun 30, 2019 | 30.75 Mn |
| Dec 31, 2018 | 39.21 Mn |
| Jun 30, 2018 | 32.15 Mn |
| Dec 31, 2017 | 3.92 Mn |